Megan Garcia is in the midst of a tough legal battle with Google and Character.ai after finding something deeply unsettling on the Character.ai platform.
Bristol Myers Squibb (BMS) is stepping up its game in drug discovery by weaving artificial intelligence (AI) and machine learning into its deep expertise